| Literature DB >> 30584908 |
Juliane Anderski1, Laura Mahlert2, Jingjiang Sun3, Wolfgang Birnbaum4, Dennis Mulac5, Sebastian Schreiber6, Fabian Herrmann7, Dirk Kuckling8, Klaus Langer9.
Abstract
Nanoparticles based on biodegradable polymers are well-known as approved carrier systems for a diversity of drugs. Despite their advantages, such as the option of an active drug targeting or the physicochemical protection of instable payloads, the controlled drug release often underlies intra- and interindividual influences and is therefore difficult to predict. To circumvent this limitation, the release behavior can be optimized using light-responsive materials for the nanoparticle preparation. The resulting light-responsive nanoparticles are able to release the embedded drug after an external light-stimulus, thereby increasing efficacy and safety of the therapy. In the present study light-responsive self-immolative polymers were used for the nanoparticle manufacturing. Light-responsive polycarbonates (LrPC) as well as PEGylated LrPC (LrPC-PEG) were synthesized via ring-opening polymerization of trimethylene carbonate-based monomers and fully physico-chemically characterized. Light-responsive nano formulations were obtained by blending LrPC or (LrPC-PEG) with the FDA-approved polymer poly(DL-lactide-co-glycolide) (PLGA). The nanoparticles were loaded with the photosensitizer 5,10,15,20-tetrakis(m-hydroxyphenyl)chlorin (mTHPC). The light-induced nanoparticle degradation was analyzed as well as the drug release behavior with and without illumination. Furthermore, biological safety of the degradation products was investigated in an in vitro cell culture study.Entities:
Keywords: Intestinal cancer; Light-responsive polymers; Nanoparticles; Photodynamic therapy; Poly(lactic-co-glycolic acid)
Mesh:
Substances:
Year: 2018 PMID: 30584908 DOI: 10.1016/j.ijpharm.2018.12.040
Source DB: PubMed Journal: Int J Pharm ISSN: 0378-5173 Impact factor: 5.875